美素佳儿母公司荷兰皇家菲仕兰，荷兰超70%牧场为美素佳儿自家牧场。乳原料和部分重要营养素(如 ARA/DHA)全自供)。从牧场到餐桌的全产业链严苛的管理和品控，经过荷兰和中国政府的双重检验。 一万余名会员奶农均需接受5年以上农牧业专业教育，严格遵循菲仕兰FOQUS全链条质量管控体系的 200余项准则，涵盖动物福利、饲料安全、环境可持续等多个维度。该体系明确要求每头奶牛每日6小时 户外放牧，奶农需详细记录放牧时间，由第三方机构Qlip进行独立评定，菲仕兰同步开展监管与乳业协 暗访监督，确保标准落地。 随着婴幼儿配方乳粉行业监管趋严与消费需求升级，原料安全与供应链可控性已成为衡量品牌核心竞争 力的关键指标。市场监管总局2025年发布的《关于进一步加强婴幼儿配方乳粉原辅料管理有关事宜的公 告》明确提出，婴配乳粉生产企业应依法依规建立生产质量管理体系，设立原辅料质量安全控制要求， 完善原辅料采购验收管理制度。在此行业背景下，荷兰皇家菲仕兰旗下美素佳儿依托百年乳业积淀，构 建全链路自主生产配料体系，以高于国际标准的品质管控，持续回应新生代父母对奶粉安全的核心关 切，树立行业品质标杆。 作为深耕中国市场的国际乳业品牌，美 ...

Core Viewpoint - The implementation of the new basic medical insurance directory and the first commercial insurance innovative drug directory starting January 1, 2026, will enhance the accessibility and affordability of innovative treatments like Baihe An (Zanidatamab) for patients with HER2-positive biliary tract cancer (BTC) [1][2]. Group 1: Drug Approval and Clinical Value - Zanidatamab is the first and only dual-specific antibody approved in China for targeting HER2 in high-expressing BTC, highlighting its unique clinical value [1][4]. - The drug has shown a 51.6% objective response rate (ORR) in previously treated, unresectable HER2-positive advanced or metastatic BTC patients, with a median overall survival (mOS) of 18.1 months [4]. Group 2: Insurance Coverage and Patient Access - The drug is covered under various "Hui Min Bao" commercial supplementary medical insurance projects across multiple regions, allowing eligible patients to receive significant reimbursement for treatment costs [2]. - The combination of the commercial insurance innovative drug directory and "Hui Min Bao" is expected to significantly improve the accessibility and affordability of this innovative drug for more patients [2]. Group 3: Broader Implications and Future Developments - The company aims to address the unmet medical needs in advanced BTC treatment, which has limited options and poor prognosis, by providing innovative therapies that enhance patient quality of life [4][8]. - Zanidatamab is also being developed for other gastrointestinal tumors, including HER2-positive metastatic gastric and colorectal cancers, indicating its potential for broader applications in oncology [5][6].

近期，北京植物医生化妆品股份有限公司在深交所主板IPO审核状态更新为"已问询"，即将登陆A股市 场，展示了DR PLANT植物医生如何通过三十年的战略定力、科研深耕与格局拓展，构建起穿越产业周 期的强大品牌力。 植物医生品牌公司创立于1994年，多年来深耕"高山植物护肤"这一核心赛道。 这种坚守并非固步自封，而是基于对消费趋势的深刻洞察。通过将中国传统高山植物智慧与现代护肤科 技相结合，植物医生成功打造了"石斛兰""紫灵芝""冬虫夏草"等标志性产品系列，在消费者心中建立 了"天然、安全、有效"的鲜明认知。值得注意的是，即使在2022年至2024年行业充满挑战的时期，公司 仍实现了营收的稳定增长与净利润的持续提升，这种穿越周期的韧性，正是长期专注所带来的必然回 报。 植物医生的"长期"除了体现在时间跨度上，更体现在对核心技术"十年磨一剑"的耐心上。 2014年，植物医生与中国科学院昆明植物研究所签订了长达20年的战略合作协议，双方联合成立的研发 中心，是实实在在的科研攻坚。值得一提的是，经过多年持续投入，团队成功从特有铁皮石斛中提取出 高活性的石斛寡糖成分，并验证了其在促进胶原蛋白生成方面的显著功效。这项"石斛 ...

Core Insights - The meeting held by Shuangyi Pharmaceutical on January 4-5, 2026, focused on summarizing the marketing achievements of 2025 and outlining the strategic direction for 2026, emphasizing the theme "Diligent Learning and Practical Work for Breakthroughs, Unity and Execution for New Heights" [1][2] Group 1: 2025 Achievements - In 2025, Shuangyi Pharmaceutical achieved significant growth, with sales and cash recovery both increasing, with cash recovery up by 56% and sales up by 25% year-on-year [2] - The core product, Compound Cold Granules, saw steady sales growth, and the medical sector made breakthrough progress in market development [1][2] Group 2: 2026 Strategic Direction - Chairman Wang Bo expressed expectations for the marketing team to enhance professional capabilities and broaden development horizons, aiming to position the company among renowned pharmaceutical brands like Beijing Tongrentang and Yunnan Baiyao [2] - Vice President Liang Liyan outlined the 2026 marketing strategy, emphasizing a "Change and Stability" approach, maintaining core structures while adapting marketing goals and strategies to market changes [3] Group 3: Team Engagement and Best Practices - The meeting included presentations from various centers, summarizing 2025 achievements and discussing 2026 marketing plans, with a focus on ensuring effective implementation through interactive discussions [3][4] - An awards ceremony recognized outstanding individuals and teams from 2025, fostering a competitive spirit and encouraging collective effort towards achieving the company's goals [5]

Group 1 - The core viewpoint of the article highlights the shift in public health awareness towards comprehensive nutritional solutions, driven by the "Healthy China 2030" initiative, with the brand Yan Professor leveraging this trend through scientific research and innovative product offerings [1] Group 2 - The product strategy of Yan Professor aligns with consumer demands for perceivable, sustainable, and systematic health improvements, featuring combinations like "Light Burn Coffee + Nutritional Simple Meal" for weight management and "0 Worry Probiotic" for gut health [3] - The brand emphasizes a holistic approach to health, integrating traditional Chinese medicine concepts with modern nutritional science through its original theory of "Balanced Intervention" [5] Group 3 - Yan Professor has established a competitive edge by training over 7,000 certified nutritionists and health managers, providing personalized dietary assessments and product recommendations through a digital platform, resulting in an average user interaction frequency of 23 times per year [7] Group 4 - The brand adopts a long-term strategy, focusing on sustainable practices and avoiding short-term trends, with a commitment to becoming a health system company for families rather than merely selling products [9]

近年来，丹阳农商银行以"变中求进、守正创新"为主线，加快推进数字化转型，有力促进了数字金融协 同发展，为普惠金融服务注入新动力。 该行积极运用科技赋能业务。上线智能财报分析系统，自动分析企业财务数据，有效辅助风险识别与授 信决策，提升流程效率。同时，构建对公数字化营销体系，明确职责分工，形成从数据分析到成效监测 的闭环管理，显著提高营销精准性与执行力。此外，创新推出移动展业平台，实现进件、审批、签约、 放款全流程线上化、无纸化办理。平台已累计服务客户超3.1万户，放款金额突破19亿元，大幅提升了 金融服务可得性与便捷性。 在风险管控方面，银行深化信用信息运用，加强内外部数据整合，通过银政、银企合作引入外部数据， 融合行内业务与管理数据，逐步积累自有数据资产。并基于客户贡献度、黏合度等维度构建客户分层管 理体系，实现对公客户的精细分类与价值挖掘，助力支行精准营销与客户价值提升。 通过一系列数字化转型举措，丹阳农商银行在普惠金融领域取得积极进展。截至目前，各项贷款较2025 年年初增长7.23%，其中普惠领域贷款增幅达8.12%，重点信贷客户数增速位列全省前列。未来，该行 将继续深化数字金融协同，依托大数据推动贷 ...

Core Insights - The meeting aimed to summarize the effectiveness of the financial dispute resolution work in 2025 and plan key tasks for 2026, emphasizing collaboration and consensus among stakeholders [1] Group 1: Project Overview - The "Jinfeng Hexin. Rong e Lou City" project has established a professional and efficient multi-governance financial dispute resolution system through mechanism co-construction, efficiency enhancement, governance deepening, and smooth collaboration [2] - The Taicang Financial Dispute Mediation Center reported on the annual mediation data, highlighting the importance of risk prevention and compliance management for financial institutions [1][2] Group 2: Future Directions - The next steps include consolidating platform functions, enhancing collaborative governance mechanisms, establishing the center as a hub for information sharing and policy coordination, and improving the professionalism and standardization of processes and services [2] - The financial regulatory department will continue to strengthen collaboration with the court in areas such as information sharing, risk prevention, and consumer rights protection to build a more robust financial risk prevention system [2] - The Taicang Court will enhance cooperation with financial regulatory agencies to improve the multi-faceted dispute resolution mechanism and upgrade the mediation center from a "dispute resolution platform" to a "governance hub" [2]

在建设工程纠纷中，高昂的鉴定费用与较长的鉴定周期，常常成为压在企业肩头的重负。近日，昆山市 人民法院依托"住建安居融诉驿站"平台，引入专家调解员开展现场勘验与专业调解，成功高效化解一起 标的额近500万元的施工合同纠纷，真正实现了"案结事了、企业共赢"。 缘起： 质保金返还纠纷，解决过程遇难题 2018年，某建设公司与某机械公司签订《建设工程施工合同》，由某建设公司承建某机械公司的多栋厂 房及附属工程项目。案涉工程于2020年1月完工并验收合格，后双方结算确认总造价为9880万元。 根据合同约定，工程总造价的5%作为质量保修金，在竣工验收后分三年逐步返还。但某机械公司未按 约返还，某建设公司遂于2025年3月诉至法院，要求某机械公司返还494万元保修金并支付违约金。某机 械公司随即提起反诉，称案涉工程存在严重漏水问题，原告未能履行维保义务，要求某建设公司支付厂 房修缮费用388万元。 本案争议焦点清晰——明确质量问题、责任承担与修复方案，但解决路径却陷入困局：若采取常用方 法、启动司法鉴定，费用高达73万余元，耗时长达4个月。 在充分了解案件背景后，承办法官并未急于要求启动鉴定程序，而是迅速转换思路，主动寻求 ...

Group 1 - Jiangsu has achieved systematic breakthroughs and endogenous growth in building a strong intellectual property province, successfully completing the "14th Five-Year" goals [1] - The province has established a large protection work pattern that matches the innovation stage, leading to a nationwide high level of protection satisfaction and quality [1] - Jiangsu has implemented ten major actions for protection and has achieved province-wide coordination in patent pre-examination, providing precise service guarantees for strategic technological forces [1] Group 2 - Jiangsu has introduced measures to strengthen foreign-related intellectual property protection, helping enterprises recover over 3 billion yuan in economic losses from overseas rights protection [2] - The province has deepened special actions for patent transformation and established a support system integrating high-value patent cultivation and regional technology transfer [2] - Jiangsu has organized the second provincial government patent award to incentivize high-quality innovation and has increased the proportion of high-value patents by 5.6 percentage points compared to the end of the "13th Five-Year" period [2] Group 3 - Jiangsu is exploring new paths for the dual empowerment of intellectual property and artificial intelligence, with a significant increase in data intellectual property registration in the industrial sector [3] - The province has published a white paper on artificial intelligence industry patents, guiding industrial innovation and accelerating the digital transformation of intellectual property governance [3] - Future goals include establishing an efficient comprehensive management system for intellectual property and creating a high ground for international intellectual property protection services [3]

Core Insights - Jiangsu Province's rural property transaction platform indicates that by 2025, over 240,000 rural property transfer transactions will occur, with a transaction value nearing 29 billion yuan, positioning the province among the top in the country [1] Group 1: Transaction Overview - The total number of rural land operating rights transactions, including cultivated land, aquaculture water surface, and "four wastelands" usage rights, exceeded 70,000, with a transaction value surpassing 12.4 billion yuan and a transferred land area of over 5.01 million acres [1] - The Rural Land Price Index (RLPI) for Jiangsu Province in 2025 is projected at 100.70, reflecting a year-on-year increase of 0.23% [1] Group 2: Price Trends - The average transaction price for rural land operating rights in 2025 is expected to be 915.47 yuan per year per acre, which is an increase of 2.06 yuan per year per acre compared to 2024, marking a year-on-year rise of 0.23% [1] - The transaction price for cultivated land in 2025 is projected at 920.67 yuan per year per acre, with an increase of 0.41 yuan per year per acre from 2024, reflecting a year-on-year growth of 0.04% [1] Group 3: Regional Price Analysis - Among the cities in Jiangsu, the top three for cultivated land transaction prices are Xuzhou, Yancheng, and Lianyungang, with prices of 954.78 yuan, 954.66 yuan, and 953.56 yuan per year per acre, respectively [2] - The top five counties for cultivated land transaction prices include Suqian's Suqian District, Yancheng's Tinghu District, Yancheng's Dafeng District, Huai'an's Hongze District, and Xuzhou's Fengxian District, with prices ranging from 991.08 yuan to 1,015.05 yuan per year per acre [2] Group 4: Data Monitoring and Indexing - Since 2018, Jiangsu Province has utilized big data analysis to quarterly release the rural land operating rights transaction price index (RLPI) for the province, 13 districts, and 51 counties, enhancing the index's representativeness [2] - To improve the accuracy of monitoring the supply and demand dynamics in the rural land operating rights market, the base period for the price index will be updated every five years, with the next update set for 2024 based on the first quarter of 2023 [2]